학술논문
Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials
Document Type
Article
Author
Source
In The Lancet Diabetes & Endocrinology October 2020 8(10):845-854
Subject
Language
ISSN
2213-8587